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IscA is a key member of the iron-sulfur cluster assembly machinery found in bacteria and eukaryotes. Previously, IscA was characterized as an alternative ironsulfur cluster assembly scaffold, as purified IscA can
host transient iron-sulfur clusters. However, recent
studies indicated that IscA is an iron-binding protein
that can provide iron for the iron-sulfur cluster assembly in a proposed scaffold IscU (Ding H., Clark, R. J., and
Ding, B. (2004) J. Biol. Chem. 279, 37499 –37504). To further elucidate the roles of IscA in the biogenesis of ironsulfur clusters, we reevaluate the iron binding activity
of IscA under physiologically relevant conditions. The
results indicate that in the presence of the thioredoxin
reductase system, Escherichia coli IscA binds iron with
an iron association constant of 2.0 ⴛ 1019 Mⴚ1 in vitro.
Whereas all three components (thioredoxin 1, thioredoxin reductase and NADPH) in the thioredoxin reductase system are essential for mediating the iron binding
in IscA, only catalytic amounts of thioredoxin 1 and
thioredoxin reductase are required. In contrast, IscU
fails to bind iron in the presence of the thioredoxin
reductase system, suggesting that the iron binding in
IscA is specific. Nevertheless, the thioredoxin reductase
system can promote the iron-sulfur cluster assembly in
IscU in the presence of the iron-loaded IscA, cysteine
desulfurase (IscS), and L-cysteine, demonstrating a
physiologically relevant system for the biogenesis of
iron-sulfur clusters. The results provide additional evidence for the hypothesis that IscA is capable of recruiting intracellular “free” iron and delivering the iron for
the iron-sulfur cluster assembly in IscU.

In Escherichia coli, the general biogenesis of iron-sulfur clusters requires at least six proteins, IscS,1 IscU, IscA, HscB,
HscA, and Ferredoxin, which are encoded by a gene cluster
iscSUA-hscBA-fdx (1, 2). IscS is a cysteine desulfurase that
catalyzes L-cysteine desulfurization (3, 4) and transfers sulfur
for the iron-sulfur cluster assembly in a proposed scaffold IscU
via specific protein-protein interactions (5–9). HscB and HscA,
a pair of heat shock cognate proteins, appear to modulate the
IscU activity (10 –12). The function of IscA, however, is not well
understood. Previously, IscA was characterized as an alternaThis work was supported by the American Heart Association and by
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tive scaffold, because IscA, like IscU, can host transient ironsulfur clusters (13–20). However, recent evidence indicated
that IscA may have more distinctive functions in the biogenesis
of iron-sulfur clusters (21–26). The genetic studies showed that
deletion of the iscU gene in Azotobacter vinelandii is lethal (26),
suggesting that IscA may not substitute for the IscU activity in
vivo. The x-ray crystallographic studies revealed that IscA may
exist as a tetramer with a central channel formed by the association of the monomers (24, 25). Within the channel, the three
invariant cysteine residues (Cys-35, Cys-99, and Cys-101) from
each IscA monomer are projected to form a “cysteine pocket,”
which could accommodate the binding of mononuclear iron
centers in the protein (22, 24, 25). None of these features were
found in the proposed scaffold IscU (27, 28). The striking difference between IscA and IscU is more evident in their iron
binding activity (21, 22). While IscA binds iron with a remarkable iron association constant in the presence of dithiothreitol,
IscU fails to do so under the same experimental conditions (22).
Furthermore, the iron-loaded IscA can efficiently provide iron
for the iron-sulfur cluster assembly in IscU when L-cysteine,
IscS, and dithiothreitol are present in the incubation solution
(21–23). Collectively, we postulated that IscA may act as an
iron chaperon that delivers iron for the biogenesis of iron-sulfur
clusters in IscU.
The pitfall of the previous biochemical characterizations of
IscA (21–23) was that the experiments were carried out in the
presence of dithiothreitol, a synthetic thiol-reducing reagent. It
could be questioned whether the observed iron binding in IscA
was an artifact of dithiothreitol and therefore physiologically
irrelevant. To further explore the roles of IscA in the biogenesis
of iron-sulfur clusters, we reevaluated the iron binding activity
of IscA under physiologically relevant conditions and found
that the E. coli thioredoxin reductase system can mediate the
iron binding in IscA and promote the iron-sulfur cluster assembly in IscU. The role of the thioredoxin reductase system in the
biogenesis of iron-sulfur clusters will be discussed.
EXPERIMENTAL PROCEDURES

Protein Purification—Recombinant E. coli IscA (22), IscU (22) and
IscS (29) were purified using a nickel-agarose column (Qiagen) followed
by a HiTrap desalting column (Amersham Biosciences). The his-tag in
purified proteins was removed by incubating with thrombin as described previously (22). E. coli thioredoxin 1 (TrxA) and thioredoxin
reductase (TrxB) were produced from the expression vectors pDL59 (30)
and pTrR301 (31), respectively. The expression vectors for TrxA and
TrxB were kindly provided by Dr. Scott B. Mulrooney (University of
Michigan). TrxA was purified following the procedure described in Ref.
30, except that a Superdex-75 gel filtration column (Amersham Biosciences) was used for the final purification step. TrxB was purified
using an ADP-Sepharose column (Amersham Biosciences) following the
procedure described in Ref. 31 and reconstituted with FAD. Both TrxA
and TrxB were purified as native form without any tags. The purity of
purified proteins was greater than 95% as judged by electrophoresis
analysis on a 15% polyacrylamide gel containing SDS followed by stain-

30432
This is an Open Access article under the CC BY license.

This paper is available on line at http://www.jbc.org

Thioredoxin Mediates Iron Binding in IscA

30433

FIG. 1. The thioredoxin reductase system promotes the iron binding in IscA. A, the absorption spectra of IscA after incubation with
ferrous iron in the presence or absence of the thioredoxin reductase system. Apo-IscA (100 M) was incubated with Fe(NH4)2(SO4)2 (100 M) in
buffer containing Tris (20 mM) (pH 8.0) and NaCl (200 mM) in the presence (spectrum a) or absence (spectrum b) of the thioredoxin reductase
system. The thioredoxin reductase system contained TrxA (10 M), TrxB (1 M), and NADPH (500 M). The reaction solution was incubated
anaerobically at 37 °C for 30 min. IscA was then repurified from the reaction solutions as described under “Experimental Procedures,” and
analyzed using the Beckman DU640 UV-visible spectrometer. B, the essential roles of TrxA, TrxB, and NADPH in mediating the iron binding in
IscA. The experiments were carried out as described in A, except one of the components was omitted in the incubation solution. The relative
amounts of the iron binding in IscA were calculated from the absorption amplitudes at 315 nm (22). The data shown are the averages from three
independent experiments.

ing with Coomassie Blue. The concentration of apo-IscA was determined using an extinction coefficient at 260 nm of 2.4 mM⫺1 cm⫺1 (22).
The concentrations of IscU, IscS, TrxA, and TrxB were determined
using extinction coefficients at 280 nm of 11.2, 39.7, 14.2, and 17.7
mM⫺1 cm⫺1, respectively (22). All protein concentrations in text were
referred to the monomeric species.
Iron Binding Analysis in IscA—Apo-IscA was prepared by incubating
purified IscA with L-cysteine (1 mM) at room temperature for 30 min
(23), followed by passing through a HiTrap desalting column to repurify
the protein (22). Prepared apo-IscA was then incubated with ferrous
iron anaerobically at 37 °C for 30 min with or without the thioredoxin
reductase system, followed by passing through a HiTrap desalting
column. In some cases, IscA was repurified from the incubation solutions using a Mono-Q column (0.98 ml) (Amersham Biosciences) (22).
The iron binding in IscA was analyzed from the absorption amplitudes
at either 315 or 430 nm of the repurified protein (22).
Iron-Sulfur Cluster Assembly in IscU—For a typical iron-sulfur cluster assembly reaction, IscU (100 M) was incubated with the ironloaded IscA (150 M), IscS (2 M), TrxA (10 M), TrxB (1 M), and
NADPH (500 M) in buffer containing NaCl (200 mM) and Tris (20 mM)
(pH 8.0). The reaction mixture was purged with pure argon gas and
preincubated at 37 °C for 5 min before L-cysteine (1 mM) was added to
initiate the iron-sulfur cluster assembly reaction. The iron-sulfur cluster assembly was monitored in a Beckman DU640 UV-visible absorption spectrometer equipped with a temperature controller. After a 30min incubation anaerobically at 37 °C, the samples were loaded onto a
Mono-Q column pre-equilibrated with buffer containing 20 mM Tris (pH
8.0) and eluted with a linear gradient of NaCl (0 –1 M) within 10 column
volumes at a flow rate of 1 ml/min. The absorption spectrum of each
fraction eluted from the column was immediately recorded. The
amounts of the iron-sulfur clusters assembled in IscU were calculated
from the amplitudes of the absorption peak at 456 nm using an extinction coefficient of 5.8 mM⫺1 cm⫺1 (5). The eluted fractions were then
subjected to the SDS-polyacrylamide gel electrophoresis analysis.
RESULTS

The Thioredoxin Reductase System Mediates the Iron Binding in IscA—In previous studies, we reported that purified
E. coli IscA has a dominant absorption peak at 315 nm with a
shoulder at 430 nm, an indicator of the iron binding in the
protein (22). The absorption peak at 315 nm and the shoulder
at 430 nm of IscA were removed after incubation with L-cysteine (23) and fully restored after reincubation with ferrous
iron in the presence of dithiothreitol, a synthetic thiol-reducing
reagent (22). Without dithiothreitol, however, iron binding in

apo-IscA (IscA devoid of iron) was negligible. Thus, the observed iron binding in IscA could be an artifact of dithiothreitol
and physiologically irrelevant.
The physiological counterpart of dithiothreitol is a group of
small proteins called the thioredoxin superfamily that provides
a thiol-reducing environment in cells (32). We chose to reevaluate the iron binding activity of IscA in the presence of thioredoxin 1 (TrxA), because TrxA represents the most abundant
thiol-reducing activity in E. coli cells (32). In the thioredoxin
reductase system, TrxA is reduced by the FAD-bound thioredoxin reductase (TrxB) using NADPH as reductant (31). For
the experiments, E. coli TrxA and TrxB were produced from
respective expression vectors and purified as described under
“Experimental Procedures.” The enzyme activity of TrxB was
examined by monitoring the oxidation of NADPH in the presence of different concentrations of TrxA. The specific enzyme
activity of TrxB was found to be comparable with that reported
by Mulrooney (31).
When apo-IscA was incubated with an equivalent amount of
ferrous iron anaerobically at 37 °C for 30 min, there was little
iron binding in IscA (Fig. 1A, spectrum b). However, when
apo-IscA was incubated with an equivalent amount of ferrous
iron in the presence of the thioredoxin reductase system anaerobically at 37 °C for 30 min, apo-IscA was converted to the
iron-loaded IscA, which has a typical absorption peak at 315
nm with a shoulder at 430 nm (Fig. 1A, spectrum a). Judging
from the ratio of the absorption amplitude at 315 nm to that at
260 nm (⬃1.06) (22), nearly all apo-IscA was transformed to the
iron-loaded IscA after incubation.
In the control experiments where one of the three components of the thioredoxin reductase system (TrxA, TrxB, and
NADPH) was omitted in the incubation solution, essentially no
iron binding in IscA was found after incubation (Fig. 1B),
indicating that all three components in the thioredoxin reductase system are necessary for mediating the iron binding in
IscA.
The iron binding activity of IscA was further examined by
titrating TrxA and NADPH in the presence of a catalytic
amount of TrxB (1 M). As shown in Fig. 2A, ⬃2 M TrxA was
sufficient to mediate the iron binding in 100 M IscA, suggest-
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FIG. 2. Titration of TrxA and NADPH in mediating the iron binding in IscA. A, apo-IscA (100 M) was incubated with Fe(NH4)2(SO4)2
(100 M), TrxB (1 M), NADPH (1 mM), and various concentrations of TrxA (0 –20 M) in buffer containing Tris (20 mM) (pH 8.0) and NaCl (200
mM) anaerobically at 37 °C for 30 min. The relative amounts of iron binding in IscA were analyzed as described in the legend for Fig. 1 and plotted
as a function of the TrxA concentrations in the solutions. B, apo-IscA (100 M) was incubated with Fe(NH4)2(SO4)2 (100 M), TrxA (10 M), TrxB
(1 M), and various concentrations of NADPH (0 –1 mM) in buffer containing Tris (20 mM) (pH 8.0) and NaCl (200 mM) anaerobically at 37 °C for
30 min. The relative amounts of iron binding in IscA were analyzed as described in the legend for Fig. 1 and plotted as a function of the NADPH
concentrations in the incubation solution. The data in the figure are the representatives from three independent experiments.

ing that TrxA, like TrxB, has a catalytic role in mediating the
iron binding in IscA. On the other hand, ⬃500 M NADPH was
required for 100 M apo-IscA to fully bind iron in the presence
of TrxA and TrxB (Fig. 2B). The results suggest that the thioredoxin reductase system facilitates the iron binding in IscA
likely through reducing the specific cysteine residues in IscA.
The Iron Binding Affinity of IscA in the Presence of the
Thioredoxin Reductase System—We then analyzed the iron
binding affinity of IscA in the presence of the thioredoxin
reductase system. Fig. 3A shows the iron binding curve of
apo-IscA. As the iron concentration in the incubation solution
was increased, the absorption peak at 315 nm of IscA was
proportionally increased and apparently saturated when the
iron concentration was about half of the monomeric IscA concentration. Analysis of the iron content in the iron-saturated
IscA samples showed that the ratio of iron to IscA monomer
was ⬃0.45:1.0, consistent with the previous report for the iron
binding of IscA in the presence of dithiothreitol (22). The sulfur
content in the IscA samples was also analyzed following the
procedure described by Beinert (33). The amounts of sulfur in
the iron-saturated IscA, apo-IscA, and the as-isolated IscA
were all negligible (data not shown), which is consistent with
the results reported previously (21–23).
In the control experiments where TrxB was not included in
the incubation solution, no iron binding in IscA was found after
incubation with increasing concentrations of ferrous iron (Fig.
3A). Similarly, without TrxA or NADPH, IscA failed to bind
iron in the solutions even with increasing concentrations of
ferrous iron (data not shown).
The iron binding activity in IscA was further investigated by
using an iron competitor, citrate, in the presence of the thioredoxin reductase system. Citrate is a physiological iron chelator
with an apparent iron association constant of 1.0 ⫻ 1017 M⫺1
(34). In this experiment, apo-IscA (100 M) was incubated with
various concentrations of citrate (0 –100 mM) in the presence of
the thioredoxin reductase system anaerobically at 37 °C for 10
min followed by addition of ferrous iron (50 M). After additional incubation at 37 °C for 30 min, the iron binding in IscA
was analyzed from its absorption peak at 315 nm. As shown in
Fig. 3B, ⬃5 mM citrate was required to compete off half of the
iron binding in 100 M IscA. Using the iron association constant of 1.0 ⫻ 1017 M⫺1 for citrate (34), we estimated that the
iron association constant of IscA in the presence of the thioredoxin reductase system is ⬃2.0 ⫻ 1019 M⫺1.

The Iron Binding Specificity of IscA in the Presence of the
Thioredoxin Reductase System—IscA has three invariant cysteine residues (Cys-35, Cys-99, and Cys-101) that are critical
for the protein function in vitro (21, 22) and in vivo (35, 36).
Like IscA, the proposed scaffold IscU also has three invariant
cysteine residues (Cys-37, Cys-63, and Cys-106) (5, 27, 28). It
would be of interest to examine whether IscU can also bind iron
in the presence of the thioredoxin reductase system.
When E. coli IscU was incubated with an equivalent amount
of ferrous iron in the presence of the thioredoxin reductase
system anaerobically at 37 °C for 30 min, the absorption spectrum of IscU was not changed before and after incubation (Fig.
4B). The iron analyses further showed that the iron content in
IscU before and after incubation was not detectable, indicating
that IscU, unlike IscA (Fig. 4A), has a fairly weak iron binding
activity in the presence of the thioredoxin reductase system.
To further determine whether the iron binding in IscA is
specific, we used an IscA mutant in which the Cys-101 was
replaced with serine (22). When the IscA mutant (C101S) was
incubated with an equivalent amount of ferrous iron in the
presence of the thioredoxin reductase system, no iron binding
in the IscA mutant was found (Fig. 4C). The same results were
obtained with the IscA mutant in which the Cys-99 was replaced with serine (data not shown). Thus, the observed iron
binding in IscA in the presence of the thioredoxin reductase
system is highly specific.
A Complete System for the Biogenesis of Iron-Sulfur Clusters—We have shown previously that the iron center in the
iron-loaded IscA can be mobilized by L-cysteine (23) and transferred for the iron-sulfur cluster assembly in IscU in the presence
of dithiothreitol (21, 22). Here, we attempted to explore a complete physiologically relevant system for the biogenesis of ironsulfur clusters. For the experiments, the iron-loaded IscA was
prepared by incubating apo-IscA with an equivalent amount of
ferrous iron in the presence of the thioredoxin reductase system
followed by repurification of IscA. The cysteine desulfurase IscS,
IscU, TrxA, and TrxB were purified as described under “Experimental Procedures” without further manipulations.
When IscU was incubated with the iron-loaded IscA, IscS,
and L-cysteine anaerobically at 37 °C, a small but observable
absorption peak at 456 nm, indicative of the iron-sulfur clusters assembly in IscU (5, 21), gradually appeared (Fig. 5A). No
absorption peak at 456 nm was observed without IscU in the
incubation solution (data not shown), consistent with the pre-
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FIG. 3. The iron binding affinity of IscA in the presence of the thioredoxin reductase system. A, the iron-binding curve of IscA in the
presence of the thioredoxin reductase system. Apo-IscA (100 M) was incubated with the thioredoxin reductase system (TrxA (10 M), TrxB (1 M),
NADPH (500 M)) and various concentrations of Fe(NH4)2(SO4)2 (0 –200 M) anaerobically at 37 °C for 30 min. The absorption amplitudes at 315
nm of repurified IscA were plotted as a function of the iron concentrations in the incubation solution. In the control experiment (dotted line), TrxB
was not included in the incubation reaction. B, the iron binding competition of apo-IscA and citrate. Apo-IscA (100 M) was incubated with the
thioredoxin reductase system (TrxA (10 M), TrxB (1 M), NADPH (500 M)) and various concentrations of sodium citrate (0 –100 mM) in buffer
containing Tris (20 mM) (pH 8.0) and NaCl (200 mM) anaerobically at 37 °C for 10 min before Fe(NH4)2(SO4)2 (50 M) was added. The incubation
reaction was continued at 37 °C for additional 30 min before the iron binding in IscA was analyzed as described in the legend for Fig. 1. The
absorption amplitudes at 315 nm of repurified IscA were plotted as a function of the concentrations of sodium citrate. The data in the figure are
the representatives from three independent experiments.

FIG. 4. The iron binding specificity
in IscA in the presence of the thioredoxin reductase system. Apo-IscA (100
M) (A), apo-IscU (100 M) (B), and the
IscA mutant 101 (Cys-101 was replaced
with serine) (100 M) (C) were incubated
with or without Fe(NH4)2(SO4)2 (100 M)
in the presence of the thioredoxin reductase system (TrxA (10 M), TrxB (1 M),
NADPH (500 M)) anaerobically at 37 °C
for 30 min, followed by repurification as
described under “Experimental Procedures.” Top spectra, the protein samples
were incubated without Fe(NH4)2(SO4)2.
Bottom spectra, the protein samples were
incubated with Fe(NH4)2(SO4)2. The experiments were repeated two times, and
similar results were obtained.

FIG. 5. A complete system for the
biogenesis of iron-sulfur clusters.
Apo-IscU (100 M) was incubated with
the iron-loaded IscA (150 M), IscS (2 M),
and L-cysteine (1 mM) in the absence (A)
or presence (B) of the thioredoxin reductase system (TrxA (10 M), TrxB (1 M),
NADPH (500 M)) anaerobically at 37 °C.
The spectra were taken every 5 min after
L-cysteine was added to initiate the ironsulfur cluster assembly reaction. The absorption peak at 456 nm indicates the assembly of the [2Fe-2S] clusters in IscU
(5). The spectra are the representatives of
three independent experiments.

vious reports that the absorption peak at 456 nm reflects the
assembly of iron-sulfur clusters in IscU (5, 21). When IscU was
incubated with the iron-loaded IscA, IscS, and L-cysteine in the
presence of the thioredoxin reductase system, a much higher
absorption peak at 456 nm was observed (Fig. 5B). If any one of
the components in the incubation solution (the iron-loaded
IscA, IscS, TrxA, TrxB, NADPH, or L-cysteine) was omitted,
only very little or no iron-sulfur clusters were assembled in
IscU (data not shown), suggesting that all six components are

necessary for the efficient biogenesis of iron-sulfur clusters in
IscU.
To further examine whether iron-sulfur clusters were assembled in IscA or IscU, we repurified both proteins from the
incubation solutions using a Mono-Q column under anaerobic
conditions. IscA and IscU were mainly eluted in fractions 8 and
10, respectively (Fig. 6, C and D). Because only catalytic
amounts of TrxA and TrxB were used in the incubation solutions, TrxA and TrxB in the eluted samples were not visible on
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FIG. 6. Iron-sulfur clusters are assembled in IscU, not in IscA. The ironsulfur cluster assembly reactions were
carried out as described in legend for Fig.
5. After incubation at 37 °C for 30 min,
the samples were loaded onto a Mono-Q
column to repurify IscA and IscU. The
eluted fractions (fractions 8, 9, and 10)
from the column were immediately subjected to the UV-visible absorption measurements, followed by the SDS-polyacrylamide gel electrophoresis analyses. A, the
absorption spectra of fractions 8 (IscA), 9,
and 10 (IscU) from the sample incubated
without the thioredoxin reductase system. B, the absorption spectra of fractions
8 (IscA), 9, and 10 (IscU) from the sample
incubated with the thioredoxin reductase
system. The absorption peak at 456 nm
reflects the [2Fe-2S] cluster assembled in
IscU. C and D, the SDS-polyacrylamide
gel analyses of the fractions shown in A
and B, respectively. Lanes 1, 2, 3, and 4 in
both panels were purified TrxB, TrxA,
IscA, and IscU, respectively.

the SDS-polyacrylamide electrophoresis gels.
When IscU was incubated with the iron-loaded IscA, L-cysteine, and IscS anaerobically, there was no indication of ironsulfur clusters assembled in IscA (Fig. 6A, fraction 8), and only a
small amount of iron-sulfur clusters assembled in IscU (Fig. 6A,
fraction 10). Using an extinction coefficient of 5.8 mM⫺1 cm⫺1 at
456 nm (5), we estimated that ⬃10% of IscU was converted to the
iron-sulfur cluster-bound IscU after incubation.
When IscU was incubated with the iron-loaded IscA, L-cysteine, and IscS in the presence of the thioredoxin reductase
system anaerobically, there was again no indication of ironsulfur clusters assembled in IscA (Fig. 6B, fraction 8). On the
other hand, a significant absorption peak at 456 nm of IscU was
observed (Fig. 6B, fraction 10). Using an extinction coefficient
of 5.8 mM⫺1 cm⫺1 at 456 nm (5), we estimated that ⬃50% of
IscU was converted to the iron-sulfur cluster-bound IscU.
These results suggest that the thioredoxin reductase system
can promote the iron-sulfur cluster assembly in IscU in the
presence of the iron-loaded IscA, IscS, and L-cysteine, demonstrating a physiologically relevant system for the biogenesis of
iron-sulfur clusters.
DISCUSSION

In the early studies, “free” ferrous iron, “free” sulfide, and a
thiol-reducing reagent dithiothreitol were often used for spontaneous reconstitution of iron-sulfur clusters in proteins in
vitro (37). It is now clear that the biogenesis of iron-sulfur
clusters is not spontaneous (38). The discovery of the cysteine
desulfurase activity (NifS) for the biogenesis of nitrogenase (39,
40) provided the first clue on how cells may utilize L-cysteine to
provide sulfur for the iron-sulfur cluster assembly. However,
the question as how the intracellular “free” iron may be mobilized and transferred for the iron-sulfur cluster assembly still
remains elusive. The intracellular “free” iron concentration is
tightly controlled, because the elevated levels of the “free” iron
content promote the production of deleterious hydroxyl free
radicals via the Fenton Reaction (41). It was thus postulated
that specific proteins must be involved in safeguarding and
delivering iron for the iron-sulfur cluster assembly. Recently,
frataxin, a mitochondrial protein linked to the human Friedreich ataxia (42), has been proposed to be a candidate for
delivering iron for the iron-sulfur cluster assembly (43, 44).
However, frataxin homologues are not essential for the biogenesis of iron-sulfur clusters in E. coli (45) and in Saccharomyces
cerevisiae (46), and frataxin appears to be capable of delivering

iron for the heme biogenesis in mitochondria (47, 48). Evidently, additional proteins could be involved in delivering iron
for the iron-sulfur cluster assembly in cells.
The results presented in this and previous studies (21–23)
suggested that E. coli IscA, the product of the third gene of the
gene cluster iscSUA-hscBA-fdx (1, 2), may fulfill the role of recruiting intracellular “free” iron and delivering the iron for the
biogenesis of iron-sulfur clusters. IscA is highly conserved from
bacteria to humans (49) with three invariant cysteine residues
(Cys-35, Cys-99, and Cys-101, E. coli numbering). In the x-ray
crystal structure models (24, 25), the invariant cysteine residues
are projected to form a “cysteine pocket,” which could accommodate the binding of mononuclear iron centers in the protein (22).
The site-directed mutagenesis studies further showed that the
invariant cysteine residues are likely involved in the iron binding, as substitution of Cys-99 or Cys-101 with serine completely
abolishes the iron binding activity of IscA (22). More importantly,
the iron-loaded IscA can provide iron for the iron-sulfur cluster
assembly in IscU in the presence of cysteine desulfurase IscS,
L-cysteine, and the thioredoxin reductase system (Figs. 5 and 6).
All these results support a notion that IscA is capable of recruiting intracellular “free” iron and delivering the iron for the biogenesis of iron-sulfur clusters.
The remarkable iron binding activity of IscA in the presence of
the thioredoxin reductase system (Fig. 3) and the ease to mobilize
the iron center in IscA by L-cysteine (23) suggest an intriguing
mechanism of the iron delivery for the biogenesis of iron-sulfur
clusters. In cells in which reduced thioredoxins are abundant
(32), IscA is expected to recruit intracellular “free” iron with an
iron association constant of 2.0 ⫻ 1019 M⫺1 (Fig. 3). When there is
a demand for the biogenesis of iron-sulfur clusters, the iron
center in IscA may be mobilized by L-cysteine for the iron-sulfur
cluster assembly (23). It is worthy mentioning that L-cysteine is
specific in mobilizing the iron center in IscA as other L-cysteinerelated small molecular thiols such as glutathione and N-acetylL-cysteine have no effect on the iron center of IscA (23). Because
L-cysteine is also the substrate of cysteine desulfurases that
provide sulfur for the iron-sulfur cluster assembly (7–9, 39, 40),
the intracellular L-cysteine content could be a major factor in
determining the mobilization of the iron center in IscA and the
overall biogenesis of iron-sulfur clusters. Evidently, the ultimate
iron source for the iron-sulfur cluster assembly could be the iron
storage proteins such as ferritin and bacterioferritin. The possi-
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ble iron exchange between IscA and the iron storage proteins
remains to be further investigated.
The observed roles of the thioredoxin reductase system in
mediating the iron binding in IscA and in promoting the ironsulfur cluster assembly in IscU suggest a potential interplay
between the metabolism of small molecular thiol proteins and
the biogenesis of iron-sulfur clusters. In E. coli, there are two
thioredoxins (thioredoxin 1 (TrxA) and thioredoxin 2 (TrxC))
and at least three glutaredoxins (glutaredoxin 1, glutaredoxin
2, and glutaredoxin 3) in the cytoplasm (32). All of these thioredoxin homologues have the Cys-X1-X2-Cys active site and a
unique thioredoxin fold and are involved in diverse physiological functions such as ribonucleotide reduction (32). Some of
these proteins have redundant functions, whereas others are
more specific (50). It was shown previously that the thioredoxin
reductase system can stimulate the assembly of the [2Fe-2S]
cluster in a redox transcription factor SoxR in the presence of
ferrous iron and sulfide in vitro (51) and that glutaredoxins can
promote the iron-sulfur cluster assembly in the oxygen sensor
FNR in the presence of L-cysteine, cysteine desulfurase (NifSAV), and ferrous iron (52). Recent genetic studies further indicated that one of the glutaredoxins (glutaredoxin 5) in S. cerevisiae is critical for the biogenesis of iron-sulfur clusters in
mitochondria (53). Because only catalytic amounts of thioredoxin 1 and thioredoxin reductase are required for mediating
the iron binding in IscA (Figs. 1 and 2) and for promoting the
iron-sulfur cluster assembly in IscU (Figs. 5 and 6), it is most
likely that the thioredoxin reductase system merely provides a
reducing environment for the biogenesis of iron-sulfur clusters.
Conceivably, a deficiency of the reduced thioredoxin 1 and its
homologues (32) would dramatically limit the overall biogenesis of iron-sulfur proteins in cells.
A picture emerging from the studies reported here and previously (21–23) is that IscS, IscU, and IscA may act in concert for
the biogenesis of iron-sulfur clusters. Whereas IscS provides sulfur (7–9), IscA may act as an iron donor for the iron-sulfur cluster
assembly in the scaffold IscU (21–23). In this reaction, L-cysteine
could have two distinct functions, mobilizing the iron center in
IscA (23) and providing sulfur via cysteine desulfurases (7–9, 39,
40) for the biogenesis of iron-sulfur clusters. It has been reported
that the expression of IscS, IscU, and IscA in the gene cluster
iscSUA-hscBA-fdx is controlled by a redox transcription factor
IscR, an iron-sulfur cluster containing protein (54). IscR normally
acts as a repressor that blocks the expression of the iscSUA genes
(54). When there is a demand for the biogenesis of iron-sulfur
clusters in cells, the iron-sulfur cluster in IscR is disassembled
and apo-IscR fails to repress the expression of the iscSUA genes,
allowing the production of IscS, IscU, and IscA (54). In this
context, we would like to propose that IscS (a sulfur donor), IscU
(a scaffold), and IscA (an iron donor) may constitute the core of
the iron-sulfur cluster assembly machinery. The other proteins
encoded by the hscBA-fdx genes (10 –12) may have important but
regulatory roles in the biogenesis of iron-sulfur clusters such as
modulating the assembly and/or transfer processes of iron-sulfur
clusters.
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